Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

14.27
Delayed Data
As of 3:59pm ET
 +0.74 / +5.47%
Today’s Change
7.70
Today|||52-Week Range
15.20
+44.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash21.6M61.4M43.3M66.8M
 
 
 
 
 
Short Term Investment Cash-72.0M34.0M-18.1M23.5M
 
 
 
 
 
Cash & Short Term Investments71.5M135.6M108.3M205.0M
 
 
 
 
 
 
ReceivablesReceivables9.1M9.1M32.4M15.7M
 
 
 
 
 
 
InventoriesInventories6.2M6.4M9.5M14.6M
 
 
 
 
 
 
Current AssetsOther Current Assets8.4M10.1M21.5M21.2M
 
 
 
 
 
Current Assets95.2M161.3M171.8M256.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross11.1M12.2M14.3M16.2M
 
 
 
 
 
Depreciation-7.6M-9.2M-10.3M-11.9M
 
 
 
 
 
Other Assets2.7M1.2M5.6M219.0K
 
 
 
 
 
Total Assets101.8M166.0M181.8M261.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.1M3.0M4.5M3.6M
 
 
 
 
 
Short Term Debt0.000.0021.9M17.4M
 
 
 
Accrued Expenses7.8M8.0M15.0M17.3M
 
 
 
 
 
Other Current Liabilities15.2M15.4M27.5M22.1M
 
 
 
 
 
Other Liabilities25.5M24.3M62.5M54.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt49.8M49.9M28.0M199.2M
 
 
 
 
 
Other Liabilities18.3K3.2M4.4M358.0K
 
 
 
 
 
Total Liabilities121.8M124.6M138.8M294.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-20.0M41.4M43.0M-32.5M
 
 
 
 
 
Total Shareholder Equity-20.0M41.4M43.0M-32.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding114.5M125.7M128.2M129.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.